DK9390D0 - Kondenserede benzapiner - Google Patents

Kondenserede benzapiner

Info

Publication number
DK9390D0
DK9390D0 DK009390A DK9390A DK9390D0 DK 9390 D0 DK9390 D0 DK 9390D0 DK 009390 A DK009390 A DK 009390A DK 9390 A DK9390 A DK 9390A DK 9390 D0 DK9390 D0 DK 9390D0
Authority
DK
Denmark
Prior art keywords
benzapines
condensed
useful
benzazepines
hypertension
Prior art date
Application number
DK009390A
Other languages
English (en)
Other versions
DK9390A (da
DK162889C (da
DK162889B (da
Inventor
Joel Gilbert Berger
Wei Kong Chang
Elijah Herman Gold
John Welch Clader
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of DK9390D0 publication Critical patent/DK9390D0/da
Publication of DK9390A publication Critical patent/DK9390A/da
Publication of DK162889B publication Critical patent/DK162889B/da
Application granted granted Critical
Publication of DK162889C publication Critical patent/DK162889C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/32Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems containing carbocyclic rings other than six-membered
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Hydrogenated Pyridines (AREA)
  • Electroluminescent Light Sources (AREA)
  • Luminescent Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK009390A 1987-07-15 1990-01-12 Substituerede hexahydrobenzindenoazepiner, fremgangsmaader til fremstilling af saadanne forbindelser, farmaceutiske praeparater indeholdende forbindelserne, anvendelse af forbindelserne til fremstilling af farmaceutiske praeparater samt fremgangsmaade til fremstilling af saadanne farmaceutiske praeparater DK162889C (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
PCT/US1987/001636 WO1989000561A1 (en) 1987-07-15 1987-07-15 Fused benzazepines
US8701636 1987-07-15
EP87110253 1987-07-16
EP87110253A EP0299101B1 (en) 1987-07-15 1987-07-16 Fused benzazepines

Publications (4)

Publication Number Publication Date
DK9390D0 true DK9390D0 (da) 1990-01-12
DK9390A DK9390A (da) 1990-03-12
DK162889B DK162889B (da) 1991-12-23
DK162889C DK162889C (da) 1992-05-11

Family

ID=26108265

Family Applications (1)

Application Number Title Priority Date Filing Date
DK009390A DK162889C (da) 1987-07-15 1990-01-12 Substituerede hexahydrobenzindenoazepiner, fremgangsmaader til fremstilling af saadanne forbindelser, farmaceutiske praeparater indeholdende forbindelserne, anvendelse af forbindelserne til fremstilling af farmaceutiske praeparater samt fremgangsmaade til fremstilling af saadanne farmaceutiske praeparater

Country Status (13)

Country Link
EP (2) EP0363353B1 (da)
JP (1) JPH0678317B2 (da)
AT (1) ATE78467T1 (da)
AU (1) AU617651B2 (da)
DE (1) DE3780649T2 (da)
DK (1) DK162889C (da)
ES (1) ES2043623T3 (da)
FI (1) FI93212C (da)
GR (1) GR3006671T3 (da)
HU (1) HU203537B (da)
NO (1) NO177264C (da)
WO (1) WO1989000561A1 (da)
ZA (1) ZA875183B (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4973586A (en) * 1986-01-16 1990-11-27 Schering Corporation Fused benzazepines, compositions of, and medical use thereof
PL168787B1 (pl) * 1989-08-03 1996-04-30 Smithkline Beecham Biolog Sposób wytwarzania czastki kompozytowej PL
US5362728A (en) * 1990-02-02 1994-11-08 Schering Corporation 4,5-bridged-2,3,4,5-tetrahydro-1H-3-benzazepine-7-ols and derivatives and compositions and methods employing such compounds
JPH07137816A (ja) * 1993-11-15 1995-05-30 Tokai Univ 地下空洞内貯蔵装置
ATE396996T1 (de) * 2002-08-29 2008-06-15 Schering Corp Selektive d1/d5 rezeptorantagonisten zur behandlung von fettleibigkeit und von zns störungen
US7504391B2 (en) * 2003-05-22 2009-03-17 Schering Corporation Selective D1/D5 receptor antagonists for the treatment of obesity and CNS disorders

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3393192A (en) * 1965-04-26 1968-07-16 Schering Corp Novel benzazepines
CH481110A (de) * 1967-02-17 1969-11-15 Geigy Ag J R Verfahren zur Herstellung von 1,2,4,5-Tetrahydro-3-azepinen
US4680298A (en) * 1983-05-31 1987-07-14 Schering Corporation Tricyclic anti-allergy and use as anti-inflammatory agents
HU199805B (en) * 1986-01-16 1990-03-28 Schering Corp Process for producing condensed benzazepine derivatives and pharmaceutical compositions comprising such compounds

Also Published As

Publication number Publication date
ES2043623T3 (es) 1994-01-01
FI900175A0 (fi) 1990-01-12
EP0363353A1 (en) 1990-04-18
DK9390A (da) 1990-03-12
DK162889C (da) 1992-05-11
JPH02504629A (ja) 1990-12-27
NO177264B (no) 1995-05-08
NO177264C (no) 1995-08-16
EP0363353B1 (en) 1992-07-22
JPH0678317B2 (ja) 1994-10-05
NO900186D0 (no) 1990-01-12
EP0299101A1 (en) 1989-01-18
DK162889B (da) 1991-12-23
ZA875183B (en) 1988-04-08
AU617651B2 (en) 1991-12-05
WO1989000561A1 (en) 1989-01-26
NO900186L (no) 1990-01-12
EP0299101B1 (en) 1992-09-23
HU203537B (en) 1991-08-28
DE3780649T2 (de) 1992-12-10
FI93212C (fi) 1995-03-10
ATE78467T1 (de) 1992-08-15
DE3780649D1 (de) 1992-08-27
GR3006671T3 (da) 1993-06-30
FI93212B (fi) 1994-11-30
AU8037887A (en) 1989-02-13

Similar Documents

Publication Publication Date Title
CA2000786A1 (en) 3-piperidinyl-1,2-benzisoxazoles
EP0626402A3 (en) Process for the preparation of linear monofunctional and bifunctional telechelic polymers and compositions made therefrom.
BR9407910A (pt) Composto composiçao farmacêutica uso do composto processo de tratamento de distúrbios no sistema nervoso central e processo de preparaçao do composto
WO1987004430A3 (en) Fused benzazepines
NO20013941D0 (no) Polynukleotider med forkortet kjede og fremgangsmate ved fremstillingen derav
DE3885366D1 (de) Verfahren zur Herstellung von Pyrrolo-(3,4-c)pyrrolen.
DE3882775D1 (de) Zusammensetzung zur behandlung von parodontaler krankheit.
DK0400522T3 (da) Fremgangsmåde til fremstilling af mikroniserede bionedbrydelige partikler
PT80752B (pt) Processo de preparacao de composicoes farmaceuticas solidas contendo di-hidropiridinas
DK9390D0 (da) Kondenserede benzapiner
CS395691A3 (en) 2-aryl-5-(trifluoromethyl)-2-pyrroline compounds and process for preparinginsecticidal 2-aryl-1-(alkoxymethyl)-4-halogen-5-(trifluoromethyl)pyrroles
DE59510180D1 (de) Verfahren zur Herstellung von 4-Amino-2,2,6,6-tetramethyl-piperidin
ATE121420T1 (de) Verfahren zur herstellung von 3-(l-pyroglutamyl)- l-thiazolidin-4-carbonsäure-derivaten.
FI891473A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten 4-aryyli-4-piperidiinikarbinolien valmistamiseksi
DK598687D0 (da) Detergentkomposition
FR2376135A1 (fr) Aminoethoxy-3 pyrrolidines substituees en position 1, utiles comme medi
DE59103040D1 (de) Verfahren zur Herstellung von symmetrischen 2,2'-Methylen-bis-benztriazolylphenolen.
DE59812284D1 (de) Verfahren zur Herstellung von 4-Amino-2,2,6,6-tetramethyl-piperidin
DE69425405D1 (de) Verbessertes Verfahren zur Herstellung von 2,4-di(alkylamine)-6-alkylthio-s-Triazinen und 2,4-alkylamine-4,6-di(alkylthio)-s-Triazinen
ES549983A0 (es) Procedimiento para preparar 6-sustituido-5-feniltetrazol (1,5-a)-(1,2,4)triazol-(1,5-c)pirimidinas
DE69015411D1 (de) 5,11-Dihydro-6H-pyrido(2,3-b)(1,4)benzodiazepin-6-one und -thione und deren Verwendung bei der Vorbeugung und und Behandlung von AIDS.
DE69802312D1 (de) Verfahren zur Herstellung von 3,3',5,5'-Tetra-b-Butylbiphenol
DE69500601D1 (de) Verfahren zur Herstellung von Dianthrachinon-N,N'-dihydroazin
DE58906998D1 (de) Verfahren zur Herstellung von 4,5,6-Trichlorpyrimidin.
DE69214982D1 (de) Verfahren zur Herstellung von 2',3'-dideoxy-2',3'-didehydronukleosiden